BTIG analyst Mark Massaro maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $2 to $10.
BTIG Maintains Buy on Bionano Genomics, Raises Price Target to $10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.